Header Logo

Lisa J Herrinton PhD

TitleResearch Scientist III
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
Address2000 Broadway
Oakland CA 94612
ORCID ORCID Icon0000-0002-5702-7162 Additional info
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Lisa Herrinton, PhD, is a senior research scientist and epidemiologist at the Kaiser Permanente Northern California Division of Research. She is a standing member of the Healthcare Outcomes and Effectiveness study section at the Agency for Healthcare Research and Quality (AHRQ) and has served on study section for the Centers for Disease Control, National Eye Institute, National Cancer Institute, and other federal agencies. Dr. Herrinton has 20 years of experience using a diverse range of research methods to investigate important questions in public health and health services. Most recently, she is conducing a program in implementation research, working with Kaiser Permanente physicians and health plan leaders to identify high priority topics suitable for integrating care delivery, quality improvement, and research. In addition, Dr. Herrinton is focused on using innovative approaches to realizing value from Kaiser Permanente's electronic medical record. These efforts cover diverse clinical areas including cataract surgery, oncology, and registry building across medical and surgical specialties. Earlier, she elucidated risk factors in the development of breast, ovarian, lung, and colorectal cancer, as well as lymphoma. In autoimmune disease, she built registries in inflammatory bowel disease, rheumatology, and psoriasis. Dr. Herrinton received her doctoral training at the University of Washington and the Fred Hutchinson Cancer Research Center in Seattle, Washington, and her master's training at Harvard University. She has published more than 160 peer-reviewed publications and several book chapters. In addition, she has led numerous collaborative activities and mentored many scientists and physician-investigators. Before her training in epidemiology, she was an environmental health manager. She also served as a high school science and math teacher through the Peace Corps in Swaziland, Africa. Besides her work, Dr. Herrinton enjoys her family and friends, hiking, biking, and swimming.

    Collapse Research 
    Collapse research activities and funding
    R01EY027329     (HERRINTON, LISA J)Mar 1, 2017 - Feb 28, 2019
    NIH/NEI
    Predicting final visual acuity following cataract surgery
    Role: Principal Investigator

    R01HS021589     (HERRINTON, LISA J.)Sep 1, 2013 - Aug 31, 2015
    AHRQ
    Psoriasis treatments, cardiovascular disease, and diabetes
    Role: Principal Investigator

    R21EY022989     (HERRINTON, LISA J.)Feb 1, 2013 - Jan 31, 2015
    NIH/NEI
    Comparative Effectiveness of Prophylaxis in Cataract Surgery
    Role: Principal Investigator

    RC1AI086107     (HERRINTON, LISA J.)Sep 28, 2009 - Aug 31, 2012
    NIH/NIAID
    Kaiser Permanente Autoimmune Disease Registry
    Role: Principal Investigator

    R01CA106912     (KROUSE, ROBERT SCOTT)Sep 15, 2004 - Feb 28, 2015
    NIH/NCI
    HR-QOL in Colorectal Cancer Survivors with Stomas
    Role: Co-Principal Investigator

    R03CA099261     (HERRINTON, LISA J)Sep 30, 2002 - Aug 31, 2004
    NIH/NCI
    Epidemiology of Marginal Zone Lymphoma
    Role: Principal Investigator

    K07CA070969     (HERRINTON, LISA J)May 1, 1996 - Apr 30, 2001
    NIH/NCI
    PREVENTIVE ONCOLOGY ACADEMIC AWARDS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Peskoe SB, Arterburn D, Coleman KJ, Herrinton LJ, Daniels MJ, Haneuse S. Adjusting for selection bias due to missing data in electronic health records-based research. Stat Methods Med Res. 2021 Aug 26; 9622802211027601. PMID: 34445911.
      Citations:    
    2. Courcoulas AP, Johnson E, Arterburn DE, Haneuse S, Herrinton LJ, Fisher DP, Li RA, Theis MK, Liu L, Taylor B, Cooper J, Chin PL, Grinberg GG, Gupta A, Saurabh S, Um SS, Yenumula PR, Zelada JL, Coleman KJ. Reduction in Long-term Mortality after Sleeve Gastrectomy and Gastric Bypass Compared to Non-surgical Patients with Severe Obesity. Ann Surg. 2021 Aug 13. PMID: 34387200.
      Citations:    
    3. Li D, Doherty AR, Raju M, Liu L, Lei NY, Amsden LB, Lee JK, Levin TR, Corley DA, Herrinton LJ. Risk stratification for colorectal cancer in individuals with subtypes of serrated polyps. Gut. 2021 Aug 11. PMID: 34380653.
      Citations:    
    4. Dusendang JR, Carlson E, Lee DS, Marwaha S, Madani S, Alexeeff SE, Webber A, Goes NB, Herrinton LJ. Cohort and nested case-control study of cutaneous squamous cell carcinoma in solid organ transplant recipients, by medication. J Am Acad Dermatol. 2021 Aug 09. PMID: 34384835.
      Citations:    
    5. Teh SH, Uong S, Lin TY, Shiraga S, Li Y, Gong IY, Herrinton LJ, Li RA. Clinical Outcomes Following Regionalization of Gastric Cancer Care in a US Integrated Health Care System. J Clin Oncol. 2021 Aug 02; JCO2100480. PMID: 34339289.
      Citations:    
    6. McCleskey PE, Zimmerman B, Lieberman A, Liu L, Chen C, Gorouhi F, Jacobson CC, Lee DS, Sriram A, Thornton A, Herz AM, Mirmirani P, Herrinton LJ. Epidemiologic Analysis of Chilblains Cohorts Before and During the COVID-19 Pandemic. JAMA Dermatol. 2021 08 01; 157(8):947-953. PMID: 34160569; PMCID: PMC8223123.
      Citations:    
    7. Rahbari R, Alavi M, Alvarez JF, Perez CA, Tedesco MM, Brill E, Park JJ, Svahn J, Yutan EU, Martinez AG, Zhou M, Philipp SR, Herrinton LJ. ASO Visual Abstract: Volume Matters-Longitudinal Retrospective Cohort Study of Outcomes Following Consultation and Standardization of Adrenal Surgery. Ann Surg Oncol. 2021 Jul 03. PMID: 34218363.
      Citations:    
    8. Shorstein NH, Carolan J, Liu L, Alexeeff SE, Amsden LB, Herrinton LJ. Visual outcomes after cataract surgery: topical nonsteroidal anti-inflammatory drug prophylaxis compared with prednisolone. J Cataract Refract Surg. 2021 Jul 01; 47(7):870-877. PMID: 33315744.
      Citations:    
    9. Rahbari R, Herrinton LJ. ASO Author Reflections: Volume Matters-Longitudinal Retrospective Cohort Study of Outcomes Following Consultation and Standardization of Adrenal Surgery. Ann Surg Oncol. 2021 Jun 29. PMID: 34185209.
      Citations:    
    10. Lieu TA, Herrinton LJ, Needham T, Ford M, Liu L, Lyons D, Macapinlac J, Neugebauer R, Ng D, Prausnitz S, Robertson W, Schultz K, Stewart K, Van Den Eeden SK, Baer DM. A prognostic information system for real-time personalized care: Lessons for embedded researchers. Healthc (Amst). 2021 Jun; 8 Suppl 1:100486. PMID: 34175099.
      Citations:    
    11. Rahbari R, Alavi M, Alvarez JF, Perez CA, Tedesco MM, Brill E, Park JJ, Svahn J, Yutan EU, Martinez AG, Zhou M, Philipp SR, Herrinton LJ. Volume Matters: Longitudinal Retrospective Cohort Study of Outcomes Following Consultation and Standardization of Adrenal Surgery. Ann Surg Oncol. 2021 Jun 17. PMID: 34142292.
      Citations:    
    12. Altschuler A, Chong AJ, Alavi M, Herrinton LJ. Pediatric Surgeons' Adoption of an Innovative Laparoscopic Technique for Inguinal Hernia Repair: A Mixed Methods Study. J Laparoendosc Adv Surg Tech A. 2021 Aug; 31(8):947-953. PMID: 34042514.
      Citations:    
    13. Madani S, Marwaha S, Dusendang JR, Alexeeff S, Pham N, Chen EH, Han S, Herrinton LJ. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma. JAMA Dermatol. 2021 05 01; 157(5):559-565. PMID: 33760003; PMCID: PMC7992022.
      Citations:    
    14. Law LY, Uong SP, Vempaty HT, Nguyen VH, Baer D, Liu VX, Herrinton LJ. Regionalization of Acute Myeloid Leukemia Treatment in a Community-Based Population: Implementation and Early Results. Perm J. 2021 05; 25. PMID: 33970088.
      Citations:    
    15. Greenwood-Hickman MA, Renz A, Rosenberg DE. Corrigendum to: Motivators and Barriers to Reducing Sedentary Behavior Among Overweight and Obese Older Adults. Gerontologist. 2021 04 03; 61(3):480. PMID: 24696887.
      Citations:    
    16. Li RA, Liu L, Arterburn D, Coleman KJ, Courcoulas AP, Fisher D, Haneuse S, Johnson E, Theis MK, Yoon TK, Fisher H, Fraser JR, Herrinton LJ. Five-year Longitudinal Cohort Study of Reinterventions After Sleeve Gastrectomy and Roux-en-Y Gastric Bypass. Ann Surg. 2021 04 01; 273(4):758-765. PMID: 31188199.
      Citations:    
    17. Coleman KJ, Shu YH, Fischer H, Johnson E, Yoon TK, Taylor B, Imam T, DeRose S, Haneuse S, Herrinton LJ, Fisher D, Li RA, Theis MK, Liu L, Courcoulas AP, Smith DH, Arterburn DE, Friedman AN. Bariatric Surgery and Risk of Death in Persons with Chronic Kidney Disease. Ann Surg. 2021 Mar 03. PMID: 33914480; PMCID: PMC8413380.
      Citations:    
    18. Shorstein NH, Liu L, Carolan JA, Herrinton L. Endophthalmitis Prophylaxis Failures in Patients Injected With Intracameral Antibiotic During Cataract Surgery. Am J Ophthalmol. 2021 07; 227:166-172. PMID: 33571472; PMCID: PMC8184599.
      Citations:    
    19. Harzstark AL, Altschuler A, Amsden LB, Alavi M, Liu L, Presti JC, Brenman LM, Walker LC, Ryken RR, De Mucha Flores AC, Nichols C, Herrinton LJ. Implementation of a Multidisciplinary Expert Testicular Cancer Tumor Board Across a Large Integrated Healthcare Delivery System Via Early Case Ascertainment. JCO Clin Cancer Inform. 2021 02; 5:187-193. PMID: 33571000.
      Citations:    
    20. Koffman L, Levis AW, Arterburn D, Coleman KJ, Herrinton LJ, Cooper J, Ewing J, Fischer H, Fraser JR, Johnson E, Taylor B, Theis MK, Liu L, Courcoulas A, Li R, Fisher DP, Amsden L, Haneuse S. Investigating Bias from Missing Data in an Electronic Health Records-Based Study of Weight Loss After Bariatric Surgery. Obes Surg. 2021 05; 31(5):2125-2135. PMID: 33462670.
      Citations:    
    21. Alexeeff SE, Uong S, Liu L, Shorstein NH, Carolan J, Amsden LB, Herrinton LJ. Development and Validation of Machine Learning Models: Electronic Health Record Data To Predict Visual Acuity After Cataract Surgery. Perm J. 2020 12; 25:1. PMID: 33635778.
      Citations:    
    22. Dusendang JR, Marwaha S, Alexeeff SE, Herrinton LJ. Presentation of Rash in a Community-Based Health System. Perm J. 2020 11; 24:1-4. PMID: 33482970; PMCID: PMC7849310.
      Citations:    
    23. Carolan JA, Liu L, Alexeeff SE, Amsden LB, Shorstein NH, Herrinton LJ. Intraocular Pressure Reduction after Phacoemulsification: A Matched Cohort Study. Ophthalmol Glaucoma. 2021 May-Jun; 4(3):277-285. PMID: 33045424; PMCID: PMC8035365.
      Citations:    
    24. Fevrier HB, Liu L, Herrinton LJ, Li D. A Transparent and Adaptable Method to Extract Colonoscopy and Pathology Data Using Natural Language Processing. J Med Syst. 2020 Jul 31; 44(9):151. PMID: 32737597.
      Citations:    
    25. Dusendang JR, Marwaha S, Alexeeff SE, Crowley E, Haiman M, Pham N, Tuerk MJ, Wudka D, Hartmann M, Herrinton LJ. Association of teledermatology workflows with standardising co-management of rashes by primary care physicians and dermatologists. J Telemed Telecare. 2020 Jun 26; 1357633X20930453. PMID: 32588723.
      Citations:    
    26. Urbania TH, Dusendang JR, Herrinton LJ, Alexeeff S, Corley DA, Ely S, Patel A, Osinski T, Sakoda LC. Standardized Reporting and Management of Suspicious Findings on Chest CT Imaging Is Associated With Improved Lung Cancer Diagnosis in an Observational Study. Chest. 2020 11; 158(5):2211-2220. PMID: 32562611; PMCID: PMC7783862.
      Citations:    
    27. Li D, Liu L, Fevrier HB, Alexeeff SE, Doherty AR, Raju M, Amsden LB, Lee JK, Levin TR, Corley DA, Herrinton LJ. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps. Gastroenterology. 2020 08; 159(2):502-511.e2. PMID: 32277950.
      Citations:    
    28. Chong AJ, Herrinton L, Fevrier H. Reply to Letter to the Editor. J Pediatr Surg. 2020 07; 55(7):1421. PMID: 32430106.
      Citations:    
    29. Arterburn DE, Johnson E, Coleman KJ, Herrinton LJ, Courcoulas AP, Fisher D, Li RA, Theis MK, Liu L, Fraser JR, Haneuse S. Weight Outcomes of Sleeve Gastrectomy and Gastric Bypass Compared to Nonsurgical Treatment. Ann Surg. 2020 Mar 13. PMID: 32187033.
      Citations:    
    30. Herrinton LJ, Raine-Bennett T, Liu L, Alexeeff SE, Ramos W, Suh-Burgmann B. Outcomes of Robotic Hysterectomy for Treatment of Benign Conditions: Influence of Patient Complexity. Perm J. 2020; 24. PMID: 31905335; PMCID: PMC6972554.
      Citations:    
    31. Schwartz NRM, Hutfless S, Herrinton LJ, Amsden LB, Fevrier HB, Giefer M, Lee D, Suskind DL, Delaney JAC, Phipps AI. Proton Pump Inhibitors, H2 Blocker Use, and Risk of Inflammatory Bowel Disease in Children. J Pediatr Pharmacol Ther. 2019 Nov-Dec; 24(6):489-496. PMID: 31719810; PMCID: PMC6836698.
      Citations:    
    32. Herrinton LJ, Woodworth TS, Eworuke E, Amsden LB, Liu L, Wyeth J, Petrone A, Menzin TJ, Williams J, Goldfien R, Nguyen M. Development of an algorithm to detect methotrexate wrong frequency error using computerized health care data. Pharmacoepidemiol Drug Saf. 2019 10; 28(10):1361-1368. PMID: 31410932.
      Citations:    
    33. Herrinton L, Liu L, Carolan J, Shorstein N. Reply. J Cataract Refract Surg. 2019 08; 45(8):1212-1213. PMID: 31371014.
      Citations:    
    34. Suh-Burgmann E, Herrinton L. Lack of Standardized Terminology in Ultrasound Reports for Ovarian Cysts. JAMA Intern Med. 2019 06 01; 179(6):847-848. PMID: 31157841.
      Citations:    
    35. Lieu TA, Herrinton LJ, Buzkov DE, Liu L, Lyons D, Neugebauer R, Needham T, Ng D, Prausnitz S, Stewart K, Van Den Eeden SK, Baer DM. Developing a Prognostic Information System for Personalized Care in Real Time. EGEMS (Wash DC). 2019 Mar 25; 7(1):2. PMID: 30937324.
      Citations:    
    36. Chong AJ, Fevrier HB, Herrinton LJ. Long-term follow-up of pediatric open and laparoscopic inguinal hernia repair. J Pediatr Surg. 2019 Feb 27. PMID: 30885559.
      Citations:    
    37. Liu LH, Fevrier HB, Goldfien R, Hemmerling A, Herrinton LJ. Understanding Non-Adherence with Hydroxychloroquine Therapy in Systemic Lupus Erythematosus. J Rheumatol. 2019 Feb 01. PMID: 30709949.
      Citations:    
    38. Marwaha S, Fevrier HB, Alexeeff SE, Crowley E, Haiman M, Pham N, Tuerk MJ, Wukda D, Hartmann M, Herrinton LJ. Comparative Effectiveness Study of Face-to-Face and Teledermatology Workflows for Diagnosing Skin Cancer. J Am Acad Dermatol. 2019 Feb 01. PMID: 30738843.
      Citations:    
    39. Liu L, Herrinton LJ, Alexeeff S, Karter AJ, Amsden LB, Carolan J, Shorstein NH. Visual outcomes after cataract surgery in patients with type 2 diabetes. J Cataract Refract Surg. 2019 Apr; 45(4):404-413. PMID: 30638823.
      Citations:    
    40. Sun V, Wendel CS, Demark-Wahnefried W, Grant M, McMullen CK, Bulkley JE, Herrinton LJ, Hornbrook MC, Krouse RS. Diet and Behavior Modifications by Long-term Rectal Cancer Survivors to Manage Bowel Dysfunction-Associated Symptoms. Nutr Cancer. 2019; 71(1):89-99. PMID: 30572723.
      Citations:    
    41. Herrinton LJ, Ray GT, Wu JJ, Fireman B, Liu L, Goldfien R, Curtis JR. Anti-TNF and Physiologic Measures of Metabolic Disease in Rheumatoid Arthritis. J Clin Rheumatol. 2018 Nov 07. PMID: 30418345.
      Citations:    
    42. Suh-Burgmann E, Flanagan T, Osinski T, Alavi M, Herrinton L. Prospective Validation of a Standardized Ultrasonography-Based Ovarian Cancer Risk Assessment System. Obstet Gynecol. 2018 Nov; 132(5):1101-1111. PMID: 30303910.
      Citations:    
    43. Ge IY, Fevrier HB, Conell C, Kheraj MN, Flint AC, Smith DS, Herrinton LJ. Reducing risk of Clostridium difficile infection and overall use of antibiotic in the outpatient treatment of urinary tract infection. Ther Adv Urol. 2018 Oct; 10(10):283-293. PMID: 30186366.
      Citations:    
    44. Smith DH, Shetterly S, Flory J, Haynes K, Lu CY, Gagne JJ, Herrinton L, Nyirenda C, Patorno E, Shoaibi A, Raebel MA. Diagnosis-based cohort augmentation using laboratory results data: The case of chronic kidney disease. Pharmacoepidemiol Drug Saf. 2018 Aug; 27(8):872-877. PMID: 29932281.
      Citations:    
    45. Suh-Burgmann EJ, Flanagan T, Lee N, Osinski T, Sweet C, Lynch M, Caponigro M, Mehta J, Alavi M, Herrinton LJ. Large-Scale Implementation of Structured Reporting of Adnexal Masses on Ultrasound. J Am Coll Radiol. 2018 May; 15(5):755-761. PMID: 29571644.
      Citations:    
    46. Amsden LB, Davidson PT, Fevrier HB, Goldfien R, Herrinton LJ. Improving the quality of care and patient experience of care during the diagnosis of lupus: a qualitative study of primary care. Lupus. 2018 Jun; 27(7):1088-1099. PMID: 29546773.
      Citations:    
    47. Hornbrook MC, Grant M, Wendel C, Bulkley JE, Mcmullen CK, Altschuler A, Temple LK, Herrinton LJ, Krouse RS. Rectal Cancer Survivors' Participation in Productive Activities. Perm J. 2018; 22:17-022. PMID: 29236653.
      Citations:    
    48. Pan M, Alavi M, Herrinton LJ. Association of Inflammatory Markers with Disease Progression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. Perm J. 2018; 22:17-149. PMID: 29616914.
      Citations:    
    49. Herrinton LJ, Ray GT, Curtis JR, Wu JJ, Fireman B, Liu L, Goldfien R. An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches. Perm J. 2018; 22:17-101. PMID: 30010538.
      Citations:    
    50. Amsden LB, Shorstein NH, Fevrier H, Liu L, Carolan J, Herrinton LJ. Immediate sequential bilateral cataract surgery: surgeon preferences and concerns. Can J Ophthalmol. 2018 08; 53(4):337-341. PMID: 30119786.
      Citations:    
    51. Alavi M, Wendel CS, Krouse RS, Temple L, Hornbrook MC, Bulkley JE, McMullen CK, Grant M, Herrinton LJ. Erratum to: Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis. Ann Surg Oncol. 2017 12; 24(Suppl 3):694. PMID: 28815447.
      Citations:    
    52. Dall'Era M, Cisternas MG, Snipes K, Herrinton LJ, Gordon C, Helmick CG. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project. Arthritis Rheumatol. 2017 10; 69(10):1996-2005. PMID: 28891237.
      Citations:    
    53. Alavi M, Wendel CS, Krouse RS, Temple L, Hornbrook MC, Bulkley JE, McMullen CK, Grant M, Herrinton LJ. Predictors of Bowel Function in Long-term Rectal Cancer Survivors with Anastomosis. Ann Surg Oncol. 2017 Nov; 24(12):3596-3603. PMID: 28785900.
      Citations:    
    54. Krouse RS, Wendel CS, Garcia DO, Grant M, Temple LKF, Going SB, Hornbrook MC, Bulkley JE, McMullen CK, Herrinton LJ. Physical activity, bowel function, and quality of life among rectal cancer survivors. Qual Life Res. 2017 11; 26(11):3131-3142. PMID: 28677077.
      Citations:    
    55. Herrinton LJ, Liu L, Alexeeff S, Carolan J, Shorstein NH. Immediate Sequential vs. Delayed Sequential Bilateral Cataract Surgery: Retrospective Comparison of Postoperative Visual Outcomes. Ophthalmology. 2017 08; 124(8):1126-1135. PMID: 28438415.
      Citations:    
    56. Shorstein NH, Lucido C, Carolan J, Liu L, Slean G, Herrinton LJ. Failure Modes and Effects Analysis of bilateral same-day cataract surgery. J Cataract Refract Surg. 2017 Mar; 43(3):318-323. PMID: 28410711.
      Citations:    
    57. Slean GR, Shorstein NH, Liu L, Paschal JF, Winthrop KL, Herrinton LJ. Pathogens and antibiotic sensitivities in endophthalmitis. Clin Exp Ophthalmol. 2017 Jul; 45(5):481-488. PMID: 28013528.
      Citations:    
    58. Liu L, Shorstein NH, Amsden LB, Herrinton LJ. Natural language processing to ascertain two key variables from operative reports in ophthalmology. Pharmacoepidemiol Drug Saf. 2017 Apr; 26(4):378-385. PMID: 28052483.
      Citations:    
    59. Mcmullen C, Liu L, Bulkley JE, Hornbrook MC, Wendel C, Grant M, Altschuler A, Temple LK, Krouse RS, Herrinton L. Participation in Activities Associated With Quality of Life for Long-Term Survivors of Rectal Cancer. Perm J. 2017; 21:16-011. PMID: 28241904.
      Citations:    
    60. Flory JH, Roy J, Gagne JJ, Haynes K, Herrinton L, Lu C, Patorno E, Shoaibi A, Raebel MA. Missing laboratory results data in electronic health databases: implications for monitoring diabetes risk. J Comp Eff Res. 2017 Jan; 6(1):25-32. PMID: 27935320.
      Citations:    
    61. Brant SR, Okou DT, Simpson CL, Cutler DJ, Haritunians T, Bradfield JP, Chopra P, Prince J, Begum F, Kumar A, Huang C, Venkateswaran S, Datta LW, Wei Z, Thomas K, Herrinton LJ, Klapproth JA, Quiros AJ, Seminerio J, Liu Z, Alexander JS, Baldassano RN, Dudley-Brown S, Cross RK, Dassopoulos T, Denson LA, Dhere TA, Dryden GW, Hanson JS, Hou JK, Hussain SZ, Hyams JS, Isaacs KL, Kader H, Kappelman MD, Katz J, Kellermayer R, Kirschner BS, Kuemmerle JF, Kwon JH, Lazarev M, Li E, Mack D, Mannon P, Moulton DE, Newberry RD, Osuntokun BO, Patel AS, Saeed SA, Targan SR, Valentine JF, Wang MH, Zonca M, Rioux JD, Duerr RH, Silverberg MS, Cho JH, Hakonarson H, Zwick ME, McGovern DP, Kugathasan S. Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease. Gastroenterology. 2017 01; 152(1):206-217.e2. PMID: 27693347.
      Citations:    
    62. Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Reply. Ophthalmology. 2016 09; 123(9):e55. PMID: 27549892.
      Citations:    
    63. Curtis JR, Harrold LR, Asgari MM, Deodhar A, Salman C, Gelfand JM, Wu JJ, Herrinton LJ. Diagnostic Prevalence of Ankylosing Spondylitis Using Computerized Health Care Data, 1996 to 2009: Underrecognition in a US Health Care Setting. Perm J. 2016; 20(4):15-151. PMID: 27479952.
      Citations:    
    64. Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Herrinton LJ, Hornbrook MC, Krouse RS. Sexual Function and Health-Related Quality of Life in Long-Term Rectal Cancer Survivors. J Sex Med. 2016 07; 13(7):1071-9. PMID: 27318020.
      Citations:    
    65. Herrinton LJ, Liu L, Goldfien R, Michaels MA, Tran TN. Risk of Serious Infection for Patients with Systemic Lupus Erythematosus Starting Glucocorticoids with or without Antimalarials. J Rheumatol. 2016 08; 43(8):1503-9. PMID: 27370880.
      Citations:    
    66. Raebel MA, Shetterly S, Lu CY, Flory J, Gagne JJ, Harrell FE, Haynes K, Herrinton LJ, Patorno E, Popovic J, Selvan M, Shoaibi A, Wang X, Roy J. Methods for using clinical laboratory test results as baseline confounders in multi-site observational database studies when missing data are expected. Pharmacoepidemiol Drug Saf. 2016 07; 25(7):798-814. PMID: 27146273.
      Citations:    
    67. Navarro-Millán I, Herrinton LJ, Chen L, Harrold L, Liu L, Curtis JR. Comparative Effectiveness of Etanercept and Adalimumab in Patient Reported Outcomes and Injection-Related Tolerability. PLoS One. 2016; 11(3):e0149781. PMID: 27007811.
      Citations:    
    68. Herrinton LJ, Altschuler A, McMullen CK, Bulkley JE, Hornbrook MC, Sun V, Wendel CS, Grant M, Baldwin CM, Demark-Wahnefried W, Temple LK, Krouse RS. Conversations for providers caring for patients with rectal cancer: Comparison of long-term patient-centered outcomes for patients with low rectal cancer facing ostomy or sphincter-sparing surgery. CA Cancer J Clin. 2016 09; 66(5):387-97. PMID: 26999757.
      Citations:    
    69. Herrinton LJ, Harrold L, Salman C, Liu L, Goldfien R, Asgari M, Gelfand JM, Wu JJ, Curtis JR. Population Variations in Rheumatoid Arthritis Treatment and Outcomes, Northern California, 1998-2009. Perm J. 2016; 20(1):4-12. PMID: 26694020.
      Citations:    
    70. Herrinton LJ, Shorstein NH, Paschal JF, Liu L, Contreras R, Winthrop KL, Chang WJ, Melles RB, Fong DS. Comparative Effectiveness of Antibiotic Prophylaxis in Cataract Surgery. Ophthalmology. 2016 Feb; 123(2):287-94. PMID: 26459998.
      Citations:    
    71. Wong DC, Waxman MD, Herrinton LJ, Shorstein NH. Transient macular edema after intracameral injection of a moderately elevated dose of cefuroxime during phacoemulsification surgery. JAMA Ophthalmol. 2015 Oct; 133(10):1194-7. PMID: 26226062.
      Citations:    
    72. Shorstein NH, Liu L, Waxman MD, Herrinton LJ. Comparative Effectiveness of Three Prophylactic Strategies to Prevent Clinical Macular Edema after Phacoemulsification Surgery. Ophthalmology. 2015 Dec; 122(12):2450-6. PMID: 26409728.
      Citations:    
    73. Chongpison Y, Hornbrook MC, Harris RB, Herrinton LJ, Gerald JK, Grant M, Bulkley JE, Wendel CS, Krouse RS. Self-reported depression and perceived financial burden among long-term rectal cancer survivors. Psychooncology. 2016 11; 25(11):1350-1356. PMID: 26365584.
      Citations:    
    74. Shen L, Melles RB, Metlapally R, Barcellos L, Schaefer C, Risch N, Herrinton LJ, Wildsoet C, Jorgenson E. The Association of Refractive Error with Glaucoma in a Multiethnic Population. Ophthalmology. 2016 Jan; 123(1):92-101. PMID: 26260281.
      Citations:    
    75. Sun V, Grant M, Wendel CS, McMullen CK, Bulkley JE, Altschuler A, Ramirez M, Baldwin CM, Herrinton LJ, Hornbrook MC, Krouse RS. Dietary and Behavioral Adjustments to Manage Bowel Dysfunction After Surgery in Long-Term Colorectal Cancer Survivors. Ann Surg Oncol. 2015 Dec; 22(13):4317-24. PMID: 26159443.
      Citations:    
    76. Hutfless S, Abramson O, Heyman MB, Bayless TM, Li DK, Winthrop K, Herrinton LJ. Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis. Gastroenterol Res Pract. 2015; 2015:690581. PMID: 26074957.
      Citations:    
    77. Herrinton LJ, Liu L, Altschuler A, Dell R, Rabrenovich V, Compton-Phillips AL. Big data, miniregistries: a rapid-turnaround solution to get quality improvement data into the hands of medical specialists. Perm J. 2015; 19(2):15-21. PMID: 25785640.
      Citations:    
    78. Arterburn D, Powers JD, Toh S, Polsky S, Butler MG, Portz JD, Donahoo WT, Herrinton L, Williams RJ, Vijayadeva V, Fisher D, Bayliss EA. Comparative effectiveness of laparoscopic adjustable gastric banding vs laparoscopic gastric bypass. JAMA Surg. 2014 Dec; 149(12):1279-87. PMID: 25353723.
      Citations:    
    79. Dublin S, Johnson KE, Walker RL, Avalos LA, Andrade SE, Beaton SJ, Davis RL, Herrinton LJ, Pawloski PA, Raebel MA, Smith DH, Toh S, Caughey AB. Trends in elective labor induction for six United States health plans, 2001-2007. J Womens Health (Larchmt). 2014 Nov; 23(11):904-11. PMID: 25330378.
      Citations:    
    80. Carnahan MC, Chang WJ, Shorstein NH, Herrinton LJ. New benchmark in preventing phacoemulsification-related endophthalmitis. J Cataract Refract Surg. 2014 Sep; 40(9):1568. PMID: 25135553.
      Citations:    
    81. Wendel CS, Grant M, Herrinton L, Temple LK, Hornbrook MC, McMullen CK, Bulkley JE, Altschuler A, Krouse RS. Reliability and validity of a survey to measure bowel function and quality of life in long-term rectal cancer survivors. Qual Life Res. 2014 Dec; 23(10):2831-40. PMID: 24890826.
      Citations:    
    82. Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Curr Med Res Opin. 2014 Aug; 30(8):1687-99. PMID: 24635013.
      Citations:    
    83. Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014 Feb; 20(2):398-415. PMID: 24280882.
      Citations:    
    84. Sun V, Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Krouse RS. From diagnosis through survivorship: health-care experiences of colorectal cancer survivors with ostomies. Support Care Cancer. 2014 Jun; 22(6):1563-70. PMID: 24442998.
      Citations:    
    85. Daley MF, Newton DA, DeBar L, Newcomer SR, Pieper L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Nakasato C, Herrinton LJ, Bussing R. Accuracy of Electronic Health Record-Derived Data for the Identification of Incident ADHD. J Atten Disord. 2017 03; 21(5):416-425. PMID: 24510475.
      Citations:    
    86. Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ. Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis. J Eur Acad Dermatol Venereol. 2014 Oct; 28(10):1380-7. PMID: 24708441.
      Citations:    
    87. Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ. Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization. Dig Dis Sci. 2014 Feb; 59(2):287-94. PMID: 24173809.
      Citations:    
    88. Solomon DH, Curtis JR, Saag KG, Lii J, Chen L, Harrold LR, Herrinton LJ, Graham DJ, Kowal MK, Kuriya B, Liu L, Griffin MR, Lewis JD, Rassen JA. Cardiovascular risk in rheumatoid arthritis: comparing TNF-a blockade with nonbiologic DMARDs. Am J Med. 2013 Aug; 126(8):730.e9-730.e17. PMID: 23885678.
      Citations:    
    89. Baddley JW, Winthrop KL, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) study. Ann Rheum Dis. 2014 Nov; 73(11):1942-8. PMID: 23852763.
      Citations:    
    90. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchell EF, Stein CM, Griffin MR. Initiation of tumor necrosis factor a antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases. Arthritis Care Res (Hoboken). 2013 Jul; 65(7):1085-94. PMID: 23281339.
      Citations:    
    91. Toh S, Baker MA, Brown JS, Kornegay C, Platt R. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9. PMID: 23529063.
      Citations:    
    92. Asgari MM, Wu JJ, Gelfand JM, Salman C, Curtis JR, Harrold LR, Herrinton LJ. Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996-2009. Pharmacoepidemiol Drug Saf. 2013 Aug; 22(8):842-9. PMID: 23637091.
      Citations:    
    93. Harrold LR, Salman C, Shoor S, Curtis JR, Asgari MM, Gelfand JM, Wu JJ, Herrinton LJ. Incidence and prevalence of juvenile idiopathic arthritis among children in a managed care population, 1996-2009. J Rheumatol. 2013 Jul; 40(7):1218-25. PMID: 23588938.
      Citations:    
    94. Kulldorff M, Dashevsky I, Avery TR, Chan AK, Davis RL, Graham D, Platt R, Andrade SE, Boudreau D, Gunter MJ, Herrinton LJ, Pawloski PA, Raebel MA, Roblin D, Brown JS. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):517-23. PMID: 23512870.
      Citations:    
    95. Brown JS, Petronis KR, Bate A, Zhang F, Dashevsky I, Kulldorff M, Avery TR, Davis RL, Chan KA, Andrade SE, Boudreau D, Gunter MJ, Herrinton L, Pawloski PA, Raebel MA, Roblin D, Smith D, Reynolds R. Drug Adverse Event Detection in Health Plan Data Using the Gamma Poisson Shrinker and Comparison to the Tree-based Scan Statistic. Pharmaceutics. 2013 Mar 14; 5(1):179-200. PMID: 24300404.
      Citations:    
    96. Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR. Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster. JAMA. 2013 Mar 06; 309(9):887-95. PMID: 23462785.
      Citations:    
    97. Avery TR, Kulldorff M, Vilk Y, Li L, Cheetham TC, Dublin S, Davis RL, Liu L, Herrinton L, Brown JS. Near real-time adverse drug reaction surveillance within population-based health networks: methodology considerations for data accrual. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):488-95. PMID: 23401239.
      Citations:    
    98. Shorstein N, Winthrop K, Herrinton L. Reply: Intracameral antibiotics and endophthalmitis incidence. J Cataract Refract Surg. 2013 Feb; 39(2):313. PMID: 23332286.
      Citations:    
    99. Herrinton LJ, Harrold LR, Liu L, Raebel MA, Taharka A, Winthrop KL, Solomon DH, Curtis JR, Lewis JD, Saag KG. Association between anti-TNF-a therapy and interstitial lung disease. Pharmacoepidemiol Drug Saf. 2013 Apr; 22(4):394-402. PMID: 23359391.
      Citations:    
    100. Herrinton LJ. Regarding: a tale of two cohorts. Gastroenterology. 2013 Mar; 144(3):e21-2. PMID: 23357065.
      Citations:    
    101. Sun V, Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Baldwin CM, Krouse RS. Surviving colorectal cancer: long-term, persistent ostomy-specific concerns and adaptations. J Wound Ostomy Continence Nurs. 2013 Jan-Feb; 40(1):61-72. PMID: 23222968.
      Citations:    
    102. Haynes K, Beukelman T, Curtis JR, Newcomb C, Herrinton LJ, Graham DJ, Solomon DH, Griffin MR, Chen L, Liu L, Saag KG, Lewis JD. Tumor necrosis factor a inhibitor therapy and cancer risk in chronic immune-mediated diseases. Arthritis Rheum. 2013 Jan; 65(1):48-58. PMID: 23055441.
      Citations:    
    103. Kawatkar AA, Jacobsen SJ, Levy GD, Medhekar SS, Venkatasubramaniam KV, Herrinton LJ. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1649-56. PMID: 22674912.
      Citations:    
    104. Skeps R, McMullen CK, Wendel CS, Bulkley J, Grant M, Mohler J, Hornbrook MC, Krouse RS, Herrinton LJ. Changes in body mass index and stoma related problems in the elderly. J Geriatr Oncol. 2013 Jan; 4(1):84-9. PMID: 24071496.
      Citations:    
    105. Herrinton LJ, Liu L, Chen L, Harrold LR, Raebel MA, Curtis JR, Griffin MR, Solomon DH, Saag KG, Lewis JD. Association between anti-TNF-a therapy and all-cause mortality. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1311-20. PMID: 23065964.
      Citations:    
    106. Shorstein NH, Winthrop KL, Herrinton LJ. Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a Northern California eye department. J Cataract Refract Surg. 2013 Jan; 39(1):8-14. PMID: 23036356.
      Citations:    
    107. Grant M, McMullen CK, Altschuler A, Hornbrook MC, Herrinton LJ, Wendel CS, Baldwin CM, Krouse RS. Irrigation practices in long-term survivors of colorectal cancer with colostomies. Clin J Oncol Nurs. 2012 Oct; 16(5):514-9. PMID: 23022935.
      Citations:    
    108. Winthrop KL, Chen L, Fraunfelder FW, Ku JH, Varley CD, Suhler E, Hills WL, Gattey D, Baddley JW, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Herrinton LJ, Fraunfelder FT, Saag KG, Lewis JD, Solomon DH, Curtis JR. Initiation of anti-TNF therapy and the risk of optic neuritis: from the safety assessment of biologic ThERapy (SABER) Study. Am J Ophthalmol. 2013 Jan; 155(1):183-189.e1. PMID: 22967869.
      Citations:    
    109. Wu JJ, Nguyen TU, Poon KY, Herrinton LJ. The association of psoriasis with autoimmune diseases. J Am Acad Dermatol. 2012 Nov; 67(5):924-30. PMID: 22664308.
      Citations:    
    110. Herrinton LJ, Liu L, Levin TR, Allison JE, Lewis JD, Velayos F. Incidence and mortality of colorectal adenocarcinoma in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology. 2012 Aug; 143(2):382-9. PMID: 22609382.
      Citations:    
    111. Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW, McFarland B, Austin D, Radcliffe L, Suhler E, Choi D, Rosenbaum JT, Herrinton LJ. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2013 Jan; 72(1):37-42. PMID: 22523429.
      Citations:    
    112. Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ. Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease. Dig Dis Sci. 2012 Aug; 57(8):2149-56. PMID: 22447434.
      Citations:    
    113. Toh S, Li L, Harrold LR, Bayliss EA, Curtis JR, Liu L, Chen L, Grijalva CG, Herrinton LJ. Comparative safety of infliximab and etanercept on the risk of serious infections: does the association vary by patient characteristics? Pharmacoepidemiol Drug Saf. 2012 May; 21(5):524-34. PMID: 22411435.
      Citations:    
    114. Forrow S, Campion DM, Herrinton LJ, Nair VP, Robb MA, Wilson M, Platt R. The organizational structure and governing principles of the Food and Drug Administration's Mini-Sentinel pilot program. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:12-7. PMID: 22262588.
      Citations:    
    115. Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR. Initiation of tumor necrosis factor-a antagonists and the risk of hospitalization for infection in patients with autoimmune diseases. JAMA. 2011 Dec 07; 306(21):2331-9. PMID: 22056398.
      Citations:    
    116. Herrinton LJ, Liu L, Weng X, Lewis JD, Hutfless S, Allison JE. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease. Am J Gastroenterol. 2011 Dec; 106(12):2146-53. PMID: 22031357.
      Citations:    
    117. Kawai VK, Grijalva CG, Arbogast PG, Curtis JR, Solomon DH, Delzell E, Chen L, Ouellet-Hellstrom R, Herrinton L, Liu L, Mitchel EF, Stein CM, Griffin MR. Changes in cotherapies after initiation of disease-modifying antirheumatic drug therapy in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2011 Oct; 63(10):1415-24. PMID: 22121511.
      Citations:    
    118. Herrinton LJ, Curtis JR, Chen L, Liu L, Delzell E, Lewis JD, Solomon DH, Griffin MR, Ouellet-Hellstom R, Beukelman T, Grijalva CG, Haynes K, Kuriya B, Lii J, Mitchel E, Patkar N, Rassen J, Winthrop KL, Nourjah P, Saag KG. Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf. 2011 Nov; 20(11):1199-209. PMID: 21919113.
      Citations:    
    119. Grant M, McMullen CK, Altschuler A, Mohler MJ, Hornbrook MC, Herrinton LJ, Wendel CS, Baldwin CM, Krouse RS. Gender differences in quality of life among long-term colorectal cancer survivors with ostomies. Oncol Nurs Forum. 2011 Sep; 38(5):587-96. PMID: 21875846.
      Citations:    
    120. Herrinton LJ, Liu L, Abramson O, Jaffe ES. The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006. Pharmacoepidemiol Drug Saf. 2012 Jan; 21(1):49-52. PMID: 21823196.
      Citations:    
    121. Hornbrook MC, Wendel CS, Coons SJ, Grant M, Herrinton LJ, Mohler MJ, Baldwin CM, McMullen CK, Green SB, Altschuler A, Rawl SM, Krouse RS. Complications among colorectal cancer survivors: SF-6D preference-weighted quality of life scores. Med Care. 2011 Mar; 49(3):321-6. PMID: 21224741.
      Citations:    
    122. Winthrop KL, Baxter R, Liu L, McFarland B, Austin D, Varley C, Radcliffe L, Suhler E, Choi D, Herrinton LJ. The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti-tumor necrosis factor therapy. Pharmacoepidemiol Drug Saf. 2011 Mar; 20(3):229-35. PMID: 21351303.
      Citations:    
    123. Li DK, Zhou Z, Miao M, He Y, Wang J, Ferber J, Herrinton LJ, Gao E, Yuan W. Urine bisphenol-A (BPA) level in relation to semen quality. Fertil Steril. 2011 Feb; 95(2):625-30.e1-4. PMID: 21035116.
      Citations:    
    124. Velayos FS, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Abramson O, Perry GS, Herrinton LJ. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology. 2010 Nov; 139(5):1511-8. PMID: 20659470.
      Citations:    
    125. Rassen JA, Solomon DH, Curtis JR, Herrinton L, Schneeweiss S. Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologics. Med Care. 2010 Jun; 48(6 Suppl):S83-9. PMID: 20473213.
      Citations:    
    126. Li DK, Zhou Z, Miao M, He Y, Qing D, Wu T, Wang J, Weng X, Ferber J, Herrinton LJ, Zhu Q, Gao E, Yuan W. Relationship between urine bisphenol-A level and declining male sexual function. J Androl. 2010 Sep-Oct; 31(5):500-6. PMID: 20467048.
      Citations:    
    127. Abramson O, Durant M, Mow W, Finley A, Kodali P, Wong A, Tavares V, McCroskey E, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Perry GS, Cannon R, Herrinton LJ. Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. J Pediatr. 2010 Aug; 157(2):233-239.e1. PMID: 20400099.
      Citations:    
    128. Liu L, Herrinton LJ, Hornbrook MC, Wendel CS, Grant M, Krouse RS. Early and late complications among long-term colorectal cancer survivors with ostomy or anastomosis. Dis Colon Rectum. 2010 Feb; 53(2):200-12. PMID: 20087096.
      Citations:    
    129. Li D, Zhou Z, Qing D, He Y, Wu T, Miao M, Wang J, Weng X, Ferber JR, Herrinton LJ, Zhu Q, Gao E, Checkoway H, Yuan W. Occupational exposure to bisphenol-A (BPA) and the risk of self-reported male sexual dysfunction. Hum Reprod. 2010 Feb; 25(2):519-27. PMID: 19906654.
      Citations:    
    130. Liu L, Allison JE, Herrinton LJ. Validity of computerized diagnoses, procedures, and drugs for inflammatory bowel disease in a northern California managed care organization. Pharmacoepidemiol Drug Saf. 2009 Nov; 18(11):1086-93. PMID: 19672855.
      Citations:    
    131. Krouse RS, Herrinton LJ, Grant M, Wendel CS, Green SB, Mohler MJ, Baldwin CM, McMullen CK, Rawl SM, Matayoshi E, Coons SJ, Hornbrook MC. Health-related quality of life among long-term rectal cancer survivors with an ostomy: manifestations by sex. J Clin Oncol. 2009 Oct 01; 27(28):4664-70. PMID: 19720920.
      Citations:    
    132. Baldwin CM, Grant M, Wendel C, Hornbrook MC, Herrinton LJ, McMullen C, Krouse RS. Gender differences in sleep disruption and fatigue on quality of life among persons with ostomies. J Clin Sleep Med. 2009 Aug 15; 5(4):335-43. PMID: 19968011.
      Citations:    
    133. Lewis JD, Abramson O, Pascua M, Liu L, Asakura LM, Velayos FS, Hutfless SM, Alison JE, Herrinton LJ. Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations. Clin Gastroenterol Hepatol. 2009 Nov; 7(11):1195-201; quiz 1141-2. PMID: 19631285.
      Citations:    
    134. Mazor KM, Sabin JE, Goff SL, Smith DH, Rolnick S, Roblin D, Raebel MA, Herrinton LJ, Gurwitz JH, Boudreau D, Meterko V, Dodd KS, Platt R. Cluster randomized trials to study the comparative effectiveness of therapeutics: stakeholders' concerns and recommendations. Pharmacoepidemiol Drug Saf. 2009 Jul; 18(7):554-61. PMID: 19402030.
      Citations:    
    135. Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005. Gastroenterology. 2009 Aug; 137(2):502-11. PMID: 19445944.
      Citations:    
    136. He Y, Miao M, Herrinton LJ, Wu C, Yuan W, Zhou Z, Li DK. Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels. Environ Res. 2009 Jul; 109(5):629-33. PMID: 19426969.
      Citations:    
    137. Altschuler A, Ramirez M, Grant M, Wendel C, Hornbrook MC, Herrinton L, Krouse RS. The influence of husbands' or male partners' support on women's psychosocial adjustment to having an ostomy resulting from colorectal cancer. J Wound Ostomy Continence Nurs. 2009 May-Jun; 36(3):299-305. PMID: 19448512.
      Citations:    
    138. Brown JS, Kulldorff M, Petronis KR, Reynolds R, Chan KA, Davis RL, Graham D, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34. PMID: 19148879.
      Citations:    
    139. Lundy JJ, Coons SJ, Wendel C, Hornbrook MC, Herrinton L, Grant M, Krouse RS. Exploring household income as a predictor of psychological well-being among long-term colorectal cancer survivors. Qual Life Res. 2009 Mar; 18(2):157-61. PMID: 19132550.
      Citations:    
    140. Walsh KE, Dodd KS, Seetharaman K, Roblin DW, Herrinton LJ, Von Worley A, Usmani GN, Baer D, Gurwitz JH. Medication errors among adults and children with cancer in the outpatient setting. J Clin Oncol. 2009 Feb 20; 27(6):891-6. PMID: 19114695.
      Citations:    
    141. Allison J, Herrinton LJ, Liu L, Yu J, Lowder J. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008 Sep; 6(9):999-1003. PMID: 18774533.
      Citations:    
    142. Pressman AR, Hutfless S, Velayos F, Fireman B, Lewis JD, Allison J, Abramson O, Herrinton LJ. Patterns of infliximab use among Crohn's disease patients in a community setting. Inflamm Bowel Dis. 2008 Sep; 14(9):1265-72. PMID: 18452199.
      Citations:    
    143. Herrinton LJ, Liu L, Lewis JD, Griffin PM, Allison J. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002. Am J Gastroenterol. 2008 Aug; 103(8):1998-2006. PMID: 18796097.
      Citations:    
    144. Altschuler A, Collins B, Lewis JD, Velayos F, Allison JE, Hutfless S, Liu L, Herrinton LJ. Gastroenterologists' attitudes and self-reported practices regarding inflammatory bowel disease. Inflamm Bowel Dis. 2008 Jul; 14(7):992-9. PMID: 18300277.
      Citations:    
    145. Hutfless S, Fireman B, Kane S, Herrinton LJ. Screening differences and risk of cervical cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2008 Sep 01; 28(5):598-605. PMID: 18549465.
      Citations:    
    146. Mohler MJ, Coons SJ, Hornbrook MC, Herrinton LJ, Wendel CS, Grant M, Krouse RS. The health-related quality of life in long-term colorectal cancer survivors study: objectives, methods and patient sample. Curr Med Res Opin. 2008 Jul; 24(7):2059-70. PMID: 18544186.
      Citations:    
    147. Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599. PMID: 18398101.
      Citations:    
    148. Herrinton LJ, Liu L, Shoor S, Mines D. Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Ann Rheum Dis. 2008 Apr; 67(4):574-5. PMID: 18349167.
      Citations:    
    149. Altschuler A, Nekhlyudov L, Rolnick SJ, Greene SM, Elmore JG, West CN, Herrinton LJ, Harris EL, Fletcher SW, Emmons KM, Geiger AM. Positive, negative, and disparate--women's differing long-term psychosocial experiences of bilateral or contralateral prophylactic mastectomy. Breast J. 2008 Jan-Feb; 14(1):25-32. PMID: 18186862.
      Citations:    
    150. Brown JS, Kulldorff M, Chan KA, Davis RL, Graham D, Pettus PT, Andrade SE, Raebel MA, Herrinton L, Roblin D, Boudreau D, Smith D, Gurwitz JH, Gunter MJ, Platt R. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84. PMID: 17955500.
      Citations:    
    151. Mazor KM, Sabin JE, Boudreau D, Goodman MJ, Gurwitz JH, Herrinton LJ, Raebel MA, Roblin D, Smith DH, Meterko V, Platt R. Cluster randomized trials: opportunities and barriers identified by leaders of eight health plans. Med Care. 2007 Oct; 45(10 Supl 2):S29-37. PMID: 17909379.
      Citations:    
    152. Hutfless SM, Weng X, Liu L, Allison J, Herrinton LJ. Mortality by medication use among patients with inflammatory bowel disease, 1996-2003. Gastroenterology. 2007 Dec; 133(6):1779-86. PMID: 18054550.
      Citations:    
    153. Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007 Sep; 45(9):869-75. PMID: 17712257.
      Citations:    
    154. Herrinton LJ, Neslund-Dudas C, Rolnick SJ, Hornbrook MC, Bachman DJ, Darbinian JA, Jackson JM, Coughlin SS. Complications at the end of life in ovarian cancer. J Pain Symptom Manage. 2007 Sep; 34(3):237-43. PMID: 17606360.
      Citations:    
    155. Rolnick SJ, Altschuler A, Nekhlyudov L, Elmore JG, Greene SM, Harris EL, Herrinton LJ, Barton MB, Geiger AM, Fletcher SW. What women wish they knew before prophylactic mastectomy. Cancer Nurs. 2007 Jul-Aug; 30(4):285-91; quiz 292-3. PMID: 17666977.
      Citations:    
    156. Weng X, Liu L, Barcellos LF, Allison JE, Herrinton LJ. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol. 2007 Jul; 102(7):1429-35. PMID: 17437504.
      Citations:    
    157. Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ, Chan KA, Platt R, Hiatt D, O'Connor S. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis. 2007 Apr; 13(4):451-61. PMID: 17219403.
      Citations:    
    158. Aiello EJ, Buist DS, Wagner EH, Tuzzio L, Greene SM, Lamerato LE, Field TS, Herrinton LJ, Haque R, Hart G, Bischoff KJ, Geiger AM. Diffusion of aromatase inhibitors for breast cancer therapy between 1996 and 2003 in the Cancer Research Network. Breast Cancer Res Treat. 2008 Feb; 107(3):397-403. PMID: 17393300.
      Citations:    
    159. Fenton JJ, Rolnick SJ, Harris EL, Barton MB, Barlow WE, Reisch LM, Herrinton LJ, Geiger AM, Fletcher SW, Elmore JG. Specificity of clinical breast examination in community practice. J Gen Intern Med. 2007 Mar; 22(3):332-7. PMID: 17356964.
      Citations:    
    160. Doubeni CA, Field TS, Buist DS, Korner EJ, Bigelow C, Lamerato L, Herrinton L, Quinn VP, Hart G, Hornbrook MC, Gurwitz JH, Wagner EH. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007 Feb 01; 109(3):612-20. PMID: 17186529.
      Citations:    
    161. Rolnick SJ, Jackson J, Nelson WW, Butani A, Herrinton LJ, Hornbrook M, Neslund-Dudas C, Bachman DJ, Coughlin SS. Pain management in the last six months of life among women who died of ovarian cancer. J Pain Symptom Manage. 2007 Jan; 33(1):24-31. PMID: 17196904.
      Citations:    
    162. Jackson JM, Rolnick SJ, Coughlin SS, Neslund-Dudas C, Hornbrook MC, Darbinian J, Bachman DJ, Herrinton LJ. Social support among women who died of ovarian cancer. Support Care Cancer. 2007 May; 15(5):547-56. PMID: 17177041.
      Citations:    
    163. Clarke CA, Glaser SL, Uratsu CS, Selby JV, Kushi LH, Herrinton LJ. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50. PMID: 17114650.
      Citations:    
    164. Geiger AM, Nekhlyudov L, Herrinton LJ, Rolnick SJ, Greene SM, West CN, Harris EL, Elmore JG, Altschuler A, Liu IL, Fletcher SW, Emmons KM. Quality of life after bilateral prophylactic mastectomy. Ann Surg Oncol. 2007 Feb; 14(2):686-94. PMID: 17103066.
      Citations:    
    165. Keating NL, Herrinton LJ, Zaslavsky AM, Liu L, Ayanian JZ. Variations in hospice use among cancer patients. J Natl Cancer Inst. 2006 Aug 02; 98(15):1053-9. PMID: 16882942.
      Citations:    
    166. Geiger AM, West CN, Nekhlyudov L, Herrinton LJ, Liu IL, Altschuler A, Rolnick SJ, Harris EL, Greene SM, Elmore JG, Emmons KM, Fletcher SW. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy. J Clin Oncol. 2006 Mar 20; 24(9):1350-6. PMID: 16549829.
      Citations:    
    167. Iribarren C, Herrinton LJ, Darbinian JA, Tamarkin L, Malinowski D, Vogelman JH, Orentreich N, Baer D. Does the association between serum endostatin, an endogenous anti-angiogenic protein, and acute myocardial infarction differ by race? Vasc Med. 2006 Feb; 11(1):13-20. PMID: 16669408.
      Citations:    
    168. Elmore JG, Reisch LM, Barton MB, Barlow WE, Rolnick S, Harris EL, Herrinton LJ, Geiger AM, Beverly RK, Hart G, Yu O, Greene SM, Weiss NS, Fletcher SW. Efficacy of breast cancer screening in the community according to risk level. J Natl Cancer Inst. 2005 Jul 20; 97(14):1035-43. PMID: 16030301.
      Citations:    
    169. Herrinton LJ, Barlow WE, Yu O, Geiger AM, Elmore JG, Barton MB, Harris EL, Rolnick S, Pardee R, Husson G, Macedo A, Fletcher SW. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project. J Clin Oncol. 2005 Jul 01; 23(19):4275-86. PMID: 15795415.
      Citations:    
    170. Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW. A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices. Arch Intern Med. 2005 Mar 14; 165(5):516-20. PMID: 15767526.
      Citations:    
    171. Wagner EH, Greene SM, Hart G, Field TS, Fletcher S, Geiger AM, Herrinton LJ, Hornbrook MC, Johnson CC, Mouchawar J, Rolnick SJ, Stevens VJ, Taplin SH, Tolsma D, Vogt TM. Building a research consortium of large health systems: the Cancer Research Network. J Natl Cancer Inst Monogr. 2005; (35):3-11. PMID: 16287880.
      Citations:    
    172. Nekhlyudov L, Bower M, Herrinton LJ, Altschuler A, Greene SM, Rolnick S, Elmore JG, Harris EL, Liu A, Emmons KM, Fletcher SW, Geiger AM. Women's decision-making roles regarding contralateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005; (35):55-60. PMID: 16287886.
      Citations:    
    173. Barton MB, West CN, Liu IL, Harris EL, Rolnick SJ, Elmore JG, Herrinton LJ, Greene SM, Nekhlyudov L, Fletcher SW, Geiger AM. Complications following bilateral prophylactic mastectomy. J Natl Cancer Inst Monogr. 2005; (35):61-6. PMID: 16287887.
      Citations:    
    174. Fenton JJ, Barton MB, Geiger AM, Herrinton LJ, Rolnick SJ, Harris EL, Barlow WE, Reisch LM, Fletcher SW, Elmore JG. Screening clinical breast examination: how often does it miss lethal breast cancer? J Natl Cancer Inst Monogr. 2005; (35):67-71. PMID: 16287888.
      Citations:    
    175. West CN, Geiger AM, Greene SM, Harris EL, Liu IL, Barton MB, Elmore JG, Rolnick S, Nekhlyudov L, Altschuler A, Herrinton LJ, Fletcher SW, Emmons KM. Race and ethnicity: comparing medical records to self-reports. J Natl Cancer Inst Monogr. 2005; (35):72-4. PMID: 16287889.
      Citations:    
    176. Field TS, Buist DS, Doubeni C, Enger S, Fouayzi H, Hart G, Korner EJ, Lamerato L, Bachman DJ, Ellis J, Herrinton L, Hornbrook MC, Krajenta R, Liu L, Yao J. Disparities and survival among breast cancer patients. J Natl Cancer Inst Monogr. 2005; (35):88-95. PMID: 16287892.
      Citations:    
    177. Rolnick SJ, Hart G, Barton MB, Herrinton L, Flores SK, Paulsen KJ, Husson G, Harris EL, Geiger AM, Elmore JG, Fletcher SW. Comparing breast cancer case identification using HMO computerized diagnostic data and SEER data. Am J Manag Care. 2004 Apr; 10(4):257-62. PMID: 15124502.
      Citations:    
    178. Field TS, Cernieux J, Buist D, Geiger A, Lamerato L, Hart G, Bachman D, Krajenta R, Greene S, Hornbrook MC, Ansell G, Herrinton L, Reed G. Retention of enrollees following a cancer diagnosis within health maintenance organizations in the Cancer Research Network. J Natl Cancer Inst. 2004 Jan 21; 96(2):148-52. PMID: 14734705.
      Citations:    
    179. Husson G, Herrinton LJ, Brox WT, Finkle W, Bernstein A, Shoor S, Greenland S. A cohort study of systemic and local complications of toe prostheses. Am J Orthop (Belle Mead NJ). 2003 Dec; 32(12):585-92. PMID: 14713064.
      Citations:    
    180. Husson G, Herrinton LJ. Regarding "a case-control study of sexually transmitted disease and risk of testicular cancer". Ann Epidemiol. 2003 Aug; 13(7):541-2. PMID: 12932631.
      Citations:    
    181. Geiger AM, Greene SM, Pardee RE, Hart G, Herrinton LJ, Macedo AM, Rolnick S, Harris EL, Barton MB, Elmore JG, Fletcher SW. A computerized system to facilitate medical record abstraction in cancer research (United States). Cancer Causes Control. 2003 Jun; 14(5):469-76. PMID: 12946042.
      Citations:    
    182. Herrinton LJ, Zhao W, Husson G. Management of cryptorchism and risk of testicular cancer. Am J Epidemiol. 2003 Apr 01; 157(7):602-5. PMID: 12672679.
      Citations:    
    183. Reisch LM, Fosse JS, Beverly K, Yu O, Barlow WE, Harris EL, Rolnick S, Barton MB, Geiger AM, Herrinton LJ, Greene SM, Fletcher SW, Elmore JG. Training, quality assurance, and assessment of medical record abstraction in a multisite study. Am J Epidemiol. 2003 Mar 15; 157(6):546-51. PMID: 12631545.
      Citations:    
    184. Herrinton LJ, Brox T, Greenland S, Finkle WD, Cattolica E, Shoor S. Regarding: a cohort study of systemic and local complications following implantation of testicular prostheses. Ann Epidemiol. 2003 Jan; 13(1):73-7. PMID: 12547488.
      Citations:    
    185. McGuire V, Herrinton L, Whittemore AS. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology. 2002 Mar; 13(2):231-4. PMID: 11880767.
      Citations:    
    186. Herrinton LJ, Voigt LF, Weiss NS, Beresford SA, Wingo PA. Risk factors for synchronous primary endometrial and ovarian cancers. Ann Epidemiol. 2001 Nov; 11(8):529-33. PMID: 11709271.
      Citations:    
    187. Herrinton LJ, Husson G. Relation of childhood height and later risk of breast cancer. Am J Epidemiol. 2001 Oct 01; 154(7):618-23. PMID: 11581095.
      Citations:    
    188. Husson G, Herrinton LJ. How accurately does the medical record capture maternal history of cancer? Cancer Epidemiol Biomarkers Prev. 2000 Jul; 9(7):765-8. PMID: 10919750.
      Citations:    
    189. Herrinton LJ, Friedman GD. Cigarette smoking and risk of non-Hodgkin's lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 1998 Jan; 7(1):25-8. PMID: 9456239.
      Citations:    
    190. Herrinton LJ. Epidemiology of the Revised European-American Lymphoma Classification subtypes. Epidemiol Rev. 1998; 20(2):187-203. PMID: 9919438.
      Citations:    
    191. Herrinton LJ, Friedman GD. Methylergonovine maleate and risk of breast cancer. Ann Epidemiol. 1997 Aug; 7(6):427-9. PMID: 9279452.
      Citations:    
    192. Herrinton LJ, Lemaitre RN, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR, Weiss NS. Lactose metabolism and time to pregnancy. Fertil Steril. 1996 Sep; 66(3):384-8. PMID: 8751734.
      Citations:    
    193. Herrinton LJ, Goldoft M, Schwartz SM, Weiss NS. The incidence of non-Hodgkin's lymphoma and its histologic subtypes in Asian migrants to the United States and their descendants. Cancer Causes Control. 1996 Mar; 7(2):224-30. PMID: 8740735.
      Citations:    
    194. Herrinton LJ. The epidemiology of monoclonal gammopathy of unknown significance: a review. Curr Top Microbiol Immunol. 1996; 210:389-95. PMID: 8565582.
      Citations:    
    195. Herrinton LJ, Selby JV, Friedman GD, Quesenberry CP, Weiss NS. Case-control study of digital-rectal screening in relation to mortality from cancer of the distal rectum. Am J Epidemiol. 1995 Nov 01; 142(9):961-4. PMID: 7572977.
      Citations:    
    196. Herrinton LJ, Friedman GD, Baer D, Selby JV. Transferrin saturation and risk of cancer. Am J Epidemiol. 1995 Oct 01; 142(7):692-8. PMID: 7572938.
      Citations:    
    197. Herrinton LJ, Weiss NS, Beresford SA, Stanford JL, Wolfla DM, Feng Z, Scott CR. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol. 1995 Mar 01; 141(5):407-16. PMID: 7879785.
      Citations:    
    198. Stanford JL, Herrinton LJ, Schwartz SM, Weiss NS. Breast cancer incidence in Asian migrants to the United States and their descendants. Epidemiology. 1995 Mar; 6(2):181-3. PMID: 7742407.
      Citations:    
    199. Herrinton LJ, Friedman GD. Serum cholesterol concentration and risk of brain cancer. BMJ. 1995 Feb 11; 310(6976):367-8. PMID: 7866214.
      Citations:    
    200. Herrinton LJ, Stanford JL, Schwartz SM, Weiss NS. Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst. 1994 Sep 07; 86(17):1336-9. PMID: 8064892.
      Citations:    
    201. Friedman GD, Herrinton LJ. Obesity and multiple myeloma. Cancer Causes Control. 1994 Sep; 5(5):479-83. PMID: 7999970.
      Citations:    
    202. Herrinton LJ, Weiss NS, Koepsell TD, Daling JR, Taylor JW, Lyon JL, Swanson GM, Greenberg RS. Exposure to hair-coloring products and the risk of multiple myeloma. Am J Public Health. 1994 Jul; 84(7):1142-4. PMID: 8017540.
      Citations:    
    203. Herrinton LJ, Weiss NS. Incidence of Waldenström's macroglobulinemia. Blood. 1993 Nov 15; 82(10):3148-50. PMID: 8219203.
      Citations:    
    204. Herrinton LJ, Saftlas AF, Stanford JL, Brinton LA, Wolfe JN. Do alcohol intake and mammographic densities interact in regard to the risk of breast cancer? Cancer. 1993 May 15; 71(10):3029-35. PMID: 8490831.
      Citations:    
    205. Herrinton LJ, Weiss NS. Postmenopausal unopposed estrogens. Characteristics of use in relation to the risk of endometrial carcinoma. Ann Epidemiol. 1993 May; 3(3):308-18. PMID: 8275205.
      Citations:    
    206. Herrinton LJ, Demers PA, Koepsell TD, Weiss NS, Daling JR, Taylor JW, Lyon JL, Swanson GM, Greenberg RS. Epidemiology of the M-component immunoglobulin types of multiple myeloma. Cancer Causes Control. 1993 Mar; 4(2):83-92. PMID: 8481497.
      Citations:    
    207. Herrinton LJ, Koepsell TD, Weiss NS. Smoking and multiple myeloma. Cancer Causes Control. 1992 Jul; 3(4):391-2. PMID: 1617129.
      Citations:    
    Concepts (606)
    Explore
    _
    Co-Authors (35)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _
    -->

    © 2021 Kaiser Permanente

    KP Researcher Profiles is made possible with the support of the Kaiser Permanente Research.